IP Library › Assignment 057503/0396
Patent Assignment
Reel/Frame 057503/0396

Assignment of Assignor's Interest

Recorded: 2021-09-16 Pages: 3
Assignors
MASJEDIZADEH, MOHAMMAD
Executed: 2016-07-29
FERDOUS, ABU
Executed: 2016-08-01
Assignee
PRINCIPIA BIOPHARMA INC.
400 EAST JAMIE COURT, SUITE 302, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property (1)
Modified Release Formulations of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)Pyrazolo[3,4-D]Pyrimidin-1-Yl]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-Yl)Piperazin-1-Yl]Pent-2-Enenitrile
Application: 17/082,747 →
Publication: US 2021/0113567
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 16, 2021
From: LIN, WU
To: QUOTIENT CLINICAL LIMITED
Reel/Frame 057503/0431 →
Assignment of Assignor's Interest Sep 16, 2021
From: QUOTIENT CLINICAL LIMITED
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 057503/0486 →
Assignee Change of Address Sep 16, 2025
From: PRINCIPIA BIOPHARMA INC.
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 072881/0270 →